Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Sitagliptin in Relatives of T1D Patients
NCT05219409Phase 3Not yet recruiting
- Sponsor
- University of Milan
- Start
- Jul 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sitagliptin in type 1 diabetes mellitus (T1D), sponsored by University of Milan. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
sitagliptin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05219409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05219409.